These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 34107353)
41. Proteome-wide Profiling of Asymmetric Dimethylated Arginine in Human Breast Tumors. Ma M; Liu F; Miles HN; Kim EJ; Fields L; Xu W; Li L J Am Soc Mass Spectrom; 2023 Aug; 34(8):1692-1700. PubMed ID: 37463068 [TBL] [Abstract][Full Text] [Related]
42. Fragmentation pathways of N(G)-methylated and unmodified arginine residues in peptides studied by ESI-MS/MS and MALDI-MS. Gehrig PM; Hunziker PE; Zahariev S; Pongor S J Am Soc Mass Spectrom; 2004 Feb; 15(2):142-9. PubMed ID: 14766281 [TBL] [Abstract][Full Text] [Related]
43. The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity. Boisvert FM; Rhie A; Richard S; Doherty AJ Cell Cycle; 2005 Dec; 4(12):1834-41. PubMed ID: 16294045 [TBL] [Abstract][Full Text] [Related]
44. ETD-Based Proteomic Profiling Improves Arginine Methylation Identification and Reveals Novel PRMT5 Substrates. Lu L; Ye Z; Zhang R; Olsen JV; Yuan Y; Mao Y J Proteome Res; 2024 Mar; 23(3):1014-1027. PubMed ID: 38272855 [TBL] [Abstract][Full Text] [Related]
45. Increased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferases. Yildirim AO; Bulau P; Zakrzewicz D; Kitowska KE; Weissmann N; Grimminger F; Morty RE; Eickelberg O Am J Respir Cell Mol Biol; 2006 Oct; 35(4):436-43. PubMed ID: 16690984 [TBL] [Abstract][Full Text] [Related]
46. Human protein arginine methyltransferases (PRMTs) can be optimally active under nonphysiological conditions. Lowe TL; Clarke SG J Biol Chem; 2022 Sep; 298(9):102290. PubMed ID: 35868559 [TBL] [Abstract][Full Text] [Related]
47. Unraveling the Origins of Changing Product Specificity Properties of Arginine Methyltransferase PRMT7 by the E181D and E181D/Q329A Mutations through QM/MM MD and Free-Energy Simulations. Ren WS; Rahman A; Jiang KB; Deng H; Zhao YY; Zhang WJ; Liu K; Qian P; Guo H J Chem Theory Comput; 2022 Apr; 18(4):2631-2641. PubMed ID: 35316052 [TBL] [Abstract][Full Text] [Related]
48. Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y⁺LAT2 Carrier-Mediated Loss. Milewski K; Bogacińska-Karaś M; Fręśko I; Hilgier W; Jaźwiec R; Albrecht J; Zielińska M Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099056 [TBL] [Abstract][Full Text] [Related]
49. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Leiper J; Vallance P Cardiovasc Res; 1999 Aug; 43(3):542-8. PubMed ID: 10690326 [TBL] [Abstract][Full Text] [Related]
50. Evolutionarily divergent type II protein arginine methyltransferase in Trypanosoma brucei. Pasternack DA; Sayegh J; Clarke S; Read LK Eukaryot Cell; 2007 Sep; 6(9):1665-81. PubMed ID: 17601874 [TBL] [Abstract][Full Text] [Related]
51. A proteomic analysis of arginine-methylated protein complexes. Boisvert FM; Côté J; Boulanger MC; Richard S Mol Cell Proteomics; 2003 Dec; 2(12):1319-30. PubMed ID: 14534352 [TBL] [Abstract][Full Text] [Related]
53. The role of protein arginine methyltransferases in kidney diseases. Zhang C; Zhuang S Clin Sci (Lond); 2020 Aug; 134(15):2037-2051. PubMed ID: 32766778 [TBL] [Abstract][Full Text] [Related]
54. Reduced asymmetric dimethylarginine accumulation through inhibition of the type I protein arginine methyltransferases promotes renal fibrosis in obstructed kidneys. Wu M; Lin P; Li L; Chen D; Yang X; Xu L; Zhou B; Wang C; Zhang Y; Luo C; Ye C FASEB J; 2019 Jun; 33(6):6948-6956. PubMed ID: 30840839 [TBL] [Abstract][Full Text] [Related]
55. Protein arginine methylation of SERBP1 by protein arginine methyltransferase 1 affects cytoplasmic/nuclear distribution. Lee YJ; Hsieh WY; Chen LY; Li C J Cell Biochem; 2012 Aug; 113(8):2721-8. PubMed ID: 22442049 [TBL] [Abstract][Full Text] [Related]
56. NF90/NFAR (nuclear factors associated with dsRNA) - a new methylation substrate of the PRMT5-WD45-RioK1 complex. Cox J; Esser LM; Jüdt M; Schmitz K; Reiffert K; Grimmler M; Stork B; Wesselborg S; Peter C Biol Chem; 2022 Sep; 403(10):907-915. PubMed ID: 36040368 [TBL] [Abstract][Full Text] [Related]
57. PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. Branscombe TL; Frankel A; Lee JH; Cook JR; Yang Z; Pestka S; Clarke S J Biol Chem; 2001 Aug; 276(35):32971-6. PubMed ID: 11413150 [TBL] [Abstract][Full Text] [Related]
58. Asymmetric and symmetric protein arginine methylation in methionine-addicted human cancer cells. Holtz AG; Lowe TL; Aoki Y; Kubota Y; Hoffman RM; Clarke SG PLoS One; 2023; 18(12):e0296291. PubMed ID: 38134182 [TBL] [Abstract][Full Text] [Related]
59. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells. Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289 [TBL] [Abstract][Full Text] [Related]
60. Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming ω-NG-monomethylated arginine residues. Zurita-Lopez CI; Sandberg T; Kelly R; Clarke SG J Biol Chem; 2012 Mar; 287(11):7859-70. PubMed ID: 22241471 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]